Skip to content

Clinical Study of Drug Combined with Avatar Therapy for Auditory Verbal Hallucinations in Schizophrenia

Clinical Study of Drug Combined with Avatar Therapy for Auditory Verbal Hallucinations in Schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115546
Enrollment
Unknown
Registered
2025-12-29
Start date
2025-12-30
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Drug-combined avatar therapy ( VRT group):Avatar therapy
Drug-combined CBT (CBT group) :CognitiveBehavioralTherapy(CBT)
Drug-only group (control group):None

Sponsors

The Sixth People's Hospital of Datong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: At least two physicians at the level of attending or above made the diagnosis according to SCID-5 meeting the DSM-5 diagnostic criteria for schizophrenia; treated with antipsychotic medication for more than 8 weeks; aged 18-55 years old; gender is not limited; Han Chinese ethnicity; right-handedness; and the patients themselves or their family members/guardians agreed to participate in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: Individuals with a DSM-5 diagnosis of schizoaffective disorder, attention deficit and hyperactivity disorder, substance abuse disorder, mood disorder, mental retardation, pervasive developmental disorder, delirium, dementia, memory impairment, or other cognitive disorders; a serious unstable physical illness; colorblindness, glaucoma, or other ocular disorders; a history of epilepsy; current risk for severe impulsivity; and an inability to accurately understand the content of the various mental health rating scales or complete the computer-based.

Design outcomes

Primary

MeasureTime frame
Psychotic Symptom Rating Scales -Auditory Hallucinations;PANSS Scale for Positive and Negative Symptoms;Emotional Regulation Scale;Self-Awareness of Unconscious Motives and Desires;CBCT,Chinese Brief Neurocognitive Battery;

Countries

China

Contacts

Public ContactDe Cao

The Sixth People's Hospital of Datong

caode1113@sina.com+86 188 0352 7115

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026